This protocol is judged by an institutional critique board, an impartial group that testimonials any clinical trials involving people. If a research involves a Routine I drug, once the board approves the protocol as moral, the researchers need to submit an application for an investigational new drug (IND) selection within the FDA.If this is The 1st